Powerful shrinking technique could enable devices that compute with light
MIT researchers created tiny 3D photonic devices with features small enough to channel visible light.
MIT researchers created tiny 3D photonic devices with features small enough to channel visible light.
A new technique helps scientists measure a phenomenon that can cause quantum circuits to perform differently than expected, increasing the error in computations.
When it comes to emissions, individual driving patterns matter as much as how “green” the regional electricity mix is, MIT researchers report.
Camille Cunin PhD ’26 is transforming rigid circuitry into stretchable, signal-amplifying devices built for real-world biomedical use.
The Udall Foundation identifies and rewards future leaders in tribal public policy, Indigenous health policy, and the environment.
Faculty members and researchers were honored in recognition of their scholarship, service, and overall excellence.
With a novel design, MIT researchers overcame a stubborn problem that has limited the effectiveness of chip-based systems for lidar.
The “MetaEase” technique provides a heads-up to potential scenarios that could cause long wait-times or outages.
Assistant Professor Gabriele Farina mines the foundations of decision-making in complex multi-agent scenarios.
NanoFab Equipment Management and Operations (NEMO) system streamlines shared facilities management via tool trainings, reservations, and lab communications.
An old patent from MIT Professor Bill Freeman inspired the new “Y-zipper,” a three-sided fastener that snaps gear, robots, and art into shape at the push of a button.
By monitoring these chromosomal structures over many timescales, MIT researchers found that chromatin helps bring genes closer to their regulatory elements.
Founded by Peter Godart ’15, SM ’19, PhD ’21, the company has developed technologies for extracting critical metals and making fuel out of aluminum.
Afreen Siddiqi, Kathleen Thelen, and Vinod Vaikuntanathan, along with alumna Kate Manne, are appointed to the 2026 class of “trail-blazing fellows.”
Founded by Jake Donoghue PhD ’19 and former MIT researcher Jarrett Revels, the company is creating an AI-driven platform to help diagnose and treat disease.